About Us
- Contact Us
Our Technology
Our Science
- Pipeline
- Advantages of Gylden’s Candidates
News and Events
Menu Menu

You are here: Home1 / Conferences2 / Novel immunopeptidomic discovery of MHC class I restricted SARS-CoV-2 peptides...

Novel immunopeptidomic discovery of MHC class I restricted SARS-CoV-2 peptides for next generation COVID19 T cell priming vaccines

13th February 2025

Share this entry

Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn
Share on Tumblr
Share on Vk
Share on Reddit
Share by Mail

/wp-content/uploads/2024/10/CompanyName-300x300.png 0 0 gatekeeper /wp-content/uploads/2024/10/CompanyName-300x300.png gatekeeper2025-02-13 13:31:272025-02-13 14:00:33Novel immunopeptidomic discovery of MHC class I restricted SARS-CoV-2 peptides for next generation COVID19 T cell priming vaccines

© Gylden Pharma

Website maintained by Digital Trading

Contact Us

Characterization of the immunogenic response of a Chikungunya virus T cell adaptive...Label-free quantitative proteomics characterizes immunopathogenesis of Chikungunya...